Keywords: gsk, pfizer, pool, hiv/aids, assets, jv, drug
GSK and Pfizer pool HIV/AIDS assets in JV
Article | 16 April 2009
US drug leviathan Pfizer and UK-based giant GlaxoSmithKline have announced their intention to create a world-leading specialist HIV company. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
